News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
713,265 Results
Type
Article (46588)
Company Profile (296)
Press Release (666381)
Section
Business (209171)
Career Advice (2206)
Deals (36013)
Drug Delivery (108)
Drug Development (82256)
Employer Resources (188)
FDA (16315)
Job Trends (15221)
News (352438)
Policy (33196)
Tag
Academia (2724)
Alliances (50867)
Alzheimer's disease (1338)
Approvals (16273)
Artificial intelligence (191)
Bankruptcy (360)
Best Places to Work (11813)
Biotechnology (201)
Breast cancer (214)
Cancer (1604)
Cardiovascular disease (126)
Career advice (1845)
CAR-T (119)
Cell therapy (336)
Clinical research (65782)
Collaboration (619)
Compensation (314)
COVID-19 (2636)
C-suite (144)
Data (1511)
Diabetes (195)
Diagnostics (6370)
Earnings (85982)
Employer resources (161)
Events (114016)
Executive appointments (524)
FDA (17127)
Funding (553)
Gene therapy (238)
GLP-1 (680)
Government (4498)
Healthcare (19144)
Infectious disease (2736)
Inflammatory bowel disease (119)
Interviews (349)
IPO (16632)
Job creations (3839)
Job search strategy (1583)
Layoffs (449)
Legal (8036)
Lung cancer (238)
Manufacturing (227)
Medical device (13399)
Medtech (13404)
Mergers & acquisitions (19672)
Metabolic disorders (533)
Neuroscience (1725)
NextGen: Class of 2025 (6719)
Non-profit (4647)
Northern California (1921)
Obesity (310)
Opinion (207)
Patents (140)
People (58708)
Phase I (20481)
Phase II (28959)
Phase III (21579)
Pipeline (630)
Postmarket research (2642)
Preclinical (8885)
Radiopharmaceuticals (247)
Rare diseases (301)
Real estate (6217)
Regulatory (22272)
Research institute (2468)
Resumes & cover letters (376)
Southern California (1662)
Startups (3776)
United States (17350)
Vaccines (610)
Weight loss (219)
Date
Today (104)
Last 7 days (597)
Last 30 days (2481)
Last 365 days (35509)
2025 (2450)
2024 (35961)
2023 (40874)
2022 (51944)
2021 (56525)
2020 (54928)
2019 (47703)
2018 (35971)
2017 (33118)
2016 (32693)
2015 (38795)
2014 (32402)
2013 (27579)
2012 (29834)
2011 (30561)
2010 (29073)
Location
Africa (793)
Arizona (214)
Asia (39173)
Australia (6450)
California (4409)
Canada (1593)
China (375)
Colorado (203)
Connecticut (210)
Europe (84912)
Florida (627)
Georgia (161)
Illinois (444)
Indiana (255)
Maryland (708)
Massachusetts (3403)
Michigan (203)
Minnesota (335)
New Jersey (1245)
New York (1267)
North Carolina (833)
Northern California (1921)
Ohio (160)
Pennsylvania (1021)
South America (1172)
Southern California (1662)
Texas (650)
Utah (127)
Washington State (438)
713,265 Results for "sight sciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Sight Sciences Announces the Release of its First Sustainability Report
Sight Sciences, Inc., an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, announced that it has published its first Sustainability Report, highlighting the Company’s sustainability activities, performance, and results from the last three years.
June 10, 2024
·
4 min read
Business
Sight Sciences to Report First Quarter Financial Results on May 2, 2024
Sight Sciences, Inc. announced it will report financial results for the first quarter ended March 31, 2024, after the market close on Thursday, May 2, 2024.
April 18, 2024
·
2 min read
Business
Sight Sciences Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Financial Guidance
Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, today reported financial results for the first quarter ended March 31, 2024, and reaffirmed financial guidance for full year 2024.
May 2, 2024
·
17 min read
Biotech Bay
Sight Sciences to Present at the Upcoming 23rd Annual Needham Healthcare Conference
Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today announced it will present at the upcoming 23rd Annual Needham Healthcare Conference being held virtually.
March 26, 2024
·
2 min read
Press Releases
Sight Sciences to Present at the Piper Sandler 36th Annual Healthcare Conference
November 19, 2024
·
2 min read
Biotech Bay
Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Pressure and Medication Reductions Achieved with OMNI® Across Mild, Moderate, and Advanced Glaucoma
Sight Sciences, Inc. announced the results as published in the journal Clinical Ophthalmology of a new analysis of the ROMEO study data.
May 28, 2024
·
7 min read
Business
Sight Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024
Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”) today announced it will report financial results for the fourth quarter and full year ended December 31, 2023, after the market close on Thursday, March 7, 2024.
February 22, 2024
·
2 min read
Business
Sight Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Initiates Full Year 2024 Financial Guidance
Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”) today reported financial results for the fourth quarter and full year ended December 31, 2023, and initiated financial guidance for full year 2024.
March 7, 2024
·
19 min read
Biotech Bay
Sight Sciences Announces the Publication of Twelve-Month Results of the SAHARA RCT Demonstrating Improved Signs and Symptoms of Dry Eye Disease for TearCare Patients Crossed Over from Restasis
Sight Sciences, Inc., an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, announced the publication of the twelve-month results from the SAHARA trial.
May 28, 2024
·
9 min read
Policy
Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma Surgery
Sight Sciences, Inc. today announced that it received a positive jury trial verdict of $34 million associated with the patent infringement case it filed on September 16, 2021 against Alcon Inc., Alcon Vision, LLC, Alcon Research, LLC, and Ivantis, Inc.
April 29, 2024
·
6 min read
1 of 71,327
Next
